EXECUTION VERSION


 


Securities Purchase Agreement


July 25, 2013


 


Sequential Brands Group, Inc.


1065 Avenue of the Americas


30th Floor


New York, NY 10018


 


Ladies and Gentlemen:


 


The undersigned investors
(the “Investors”) understand Sequential Brands Group, Inc., a corporation organized under the laws of the State of
Delaware (the “Company”), is offering an aggregate of 7,000,000
shares of its common stock, par value $0.001 per share (the “Securities”)
in a private placement pursuant to Regulation D promulgated under the Securities Act of 1933, as amended (the “Securities
Act”). This offering is made pursuant to the offering materials made available to the Investors as listed on Schedule
1 hereto (the “Offering Materials”).
The undersigned further understands that the offering is being made without registration of the Securities under the Securities
Act, or any securities law of any state of the United States or of any other jurisdiction, and is being made only to “accredited
investors” (as defined in Rule 501 of Regulation D promulgated under the Securities Act).


 


1.          Purchase.
Subject to the terms and conditions hereof and as set forth in the Offering Materials, the Company agrees to sell and each of the
Investors, severally, but not jointly, agrees to purchase the number of Securities set forth opposite their respective names in
Appendix A hereto for the purchase price set forth in Appendix A, which is payable as described in Section 3 hereof.
The undersigned acknowledges that the Securities will be subject to restrictions on transfer as set forth in this Securities Purchase
Agreement (the “Purchase Agreement”) and under applicable securities
laws.


 


2.          The
Closing. The closing of the purchase and sale of the Securities (the “Closing”)
shall take place at the offices of White & Case LLP, at 10:30 a.m. on July 26, 2013, or at such other time and place as the
Company may designate by notice to the undersigned (the “Closing Date”).


 


3.          Payment
for Securities. Payment for the Securities shall be received by the Company from the Investors by wire transfer of immediately
available funds to an account designated by the Company at least twenty four (24) hours prior to 9:30 a.m., New York time, on the
Closing Date, unless otherwise agreed between the Company and each Investor, as to itself only, per the written instructions provided
to the Investors at least two business days before the Closing Date or other means approved by the Company at or prior to the Closing,
in the amount as set forth opposite each Investor’s name in Appendix A hereto. The Company shall deliver certificates
representing the Securities to each respective Investor in accordance with Section 4 hereof, bearing an appropriate legend (as
set forth below) referring to the fact that the Securities were sold in reliance upon an exemption from registration under the
Securities Act.


 




    	 



    	 



    

 


THE SECURITIES REPRESENTED
HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),
OR ANY STATE SECURITIES LAWS. THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES FOR THE BENEFIT OF THE ISSUER THAT THESE
SECURITIES MAY BE OFFERED, SOLD OR OTHERWISE TRANSFERRED ONLY (A) TO THE ISSUER, (B) PURSUANT TO REGISTRATION UNDER THE SECURITIES
ACT, (C) OUTSIDE THE UNITED STATES PURSUANT TO REGULATION S UNDER THE SECURITIES ACT, (D) INSIDE THE UNITED STATES PURSUANT
TO THE EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER, IF AVAILABLE, OR (E) IN A TRANSACTION
THAT IS OTHERWISE EXEMPT FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT, AND IN EACH CASE IN COMPLIANCE WITH APPLICABLE
STATE SECURITIES LAWS AND THE APPLICABLE LAWS OF ANY OTHER JURISDICTION, PROVIDED THAT IN THE CASE OF (C), (D) or (E) ABOVE,
THE HOLDER HAS, PRIOR TO SUCH SALE, FURNISHED TO THE ISSUER A LEGAL OPINION OF COUNSEL OF RECOGNIZED STANDING, REASONABLY SATISFACTORY
TO THE ISSUER. HEDGING TRANSACTIONS INVOLVING THESE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.


 


4.          Closing
Deliverables of the Company. On or prior to the Closing Date (or as otherwise specified in each clause below), the Company
shall deliver or cause to be delivered to each Investor the following:


 


(a)          This
Purchase Agreement, dated as of the date hereof, by and among the Company and the Investors duly executed by the Company;


 


(b)          Unless
otherwise agreed to by the Company and an Investor (as to itself only), “.pdf” copies of one or more stock certificates,
free and clear of all restrictive or other legends (except as provided in Section 3 hereof) or statements from the Company’s
transfer agent evidencing the Securities purchased by such Investor hereunder, registered in the name of such Investor as set forth
in Appendix A hereto (the “Stock Certificates”) with the original Stock Certificates to be delivered by the
Company’s transfer agent to the registered address of each Investor, as set forth in Appendix A hereto, promptly after
the Closing Date but no later than five business days from the Closing Date;


 


(c)          That
certain registration rights agreement, dated as of the Closing Date, by and among the Company and the investors signatory thereto
(the “Registration Rights Agreement”) duly executed by the Company;


 




    	2



    	 



    

 


(d)          A
certificate of the secretary of the Company, dated as of the Closing Date, (i) certifying resolutions adopted by the Company’s
board of directors, or a duly authorized committee thereof, approving the transactions contemplated in this Purchase Agreement,
the Registration Rights Agreement and any other documents or agreements executed in connection with the transactions contemplated
hereunder (together, the “Transaction Documents”) and the issuance of the Securities, (ii) certifying the current versions
of the Company’s certificate of incorporation and by-laws, each as amended, and (iii) certifying as to the signatures and
authority of persons signing the Transaction Documents and related documents on behalf of the Company;


 


(e)          A
certificate of an executive officer of the Company, dated as of the Closing Date, certifying to the satisfaction of the conditions
in Sections 6(b)(i) and (ii); and


 


(f)          An
opinion, dated as of the Closing Date, from White & Case LLP, as counsel to the Company, stating that (i) the Securities will
be validly issued, fully paid and non-assessable and (ii) it is not necessary in connection with the issuance, sale and delivery
to the Investors of the Securities by the Company under the circumstances contemplated by this Purchase Agreement and the Offering
Materials to register the Securities under the Securities Act.


 


5.          Closing
Deliverables of the Undersigned Investors. On or prior to the Closing Date (or as otherwise specified in each clause below),
each Investor shall deliver or cause to be delivered to the Company the following:


 


(a)          The
purchase price to be paid, in United States dollars and immediately available funds as set forth in Appendix A hereto, by
wire transfer directly to an account designated by the Company as provided for in Section 3 hereof;


 


(b)          A
fully completed and duly executed investor questionnaire dated on or prior to the commencement of this offering; and


 


(c)          This
Purchase Agreement, the Registration Rights Agreement and any other documents or agreements executed in connection with the transactions
contemplated hereunder duly executed by such Investor.


 


6.          Closing
Conditions.


 


(a)          The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met by the Investors
or waived by the Company:


 


(i)          The
accuracy in all material respects, when made and as of the Closing Date, of the representations and warranties of the Investors
contained herein (except with respect to representations and warranties which relate to a specific date, in which case such representations
and warranties shall continue to be materially accurate as of such date).


 




    	3



    	 



    

 


(ii)         All
obligations, covenants and agreements of the Investors required to be performed at or prior to the Closing shall have been performed.


 


(iii)        The
delivery by the Investors of the items set forth in Section 5 of this Purchase Agreement.


 


(iv)        No
statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated
by the Transaction Documents.


 


(b)          The
respective obligations of the Investors hereunder in connection with the Closing are subject to the following conditions being
met by the Company or waived by each Investor as to itself:


 


(i)          The
accuracy in all material respects, when made and as of the Closing, of the representations and warranties of the Company contained
herein (except with respect to representations and warranties which relate to a specific date, in which case such representations
and warranties shall continue to be materially accurate as of such date).


 


(ii)         All
obligations, covenants and agreements of the Company contained herein required to be performed at or prior to the Closing shall
have been performed.


 


(iii)        No
statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated
by the Transaction Documents.


 


(iv)        The
Company shall have obtained in a timely fashion any and all consents, permits, approvals, registrations and waivers necessary for
consummation of the purchase and sale of the Securities, all of which shall be and remain so long as necessary in full force and
effect.


 




    	4



    	 



    

 


7.          Representations
and Warranties of the Company. The Company represents and warrants that:


 


(a)          The
Company is duly formed and validly existing under the laws of the State of Delaware, with the requisite corporate power and authority
to conduct its business as it is currently being conducted and to own or lease its assets and has secured any other authorizations,
approvals, permits and orders required by law for the conduct by the Company of its business as it is currently being conducted.


 


(b)          The
Company has the requisite corporate power and authority to enter into and perform the Transaction Documents and to issue the Securities
in accordance with the terms hereof. The execution, delivery and performance of the Transaction Documents by the Company and the
consummation by it of the transactions contemplated hereby have been duly and validly authorized by all necessary corporate action,
and no further consent or authorization of the Company, its board of directors or stockholders is required. When executed and delivered
by the Company, the Transaction Documents shall constitute a valid and binding obligation of the Company, enforceable against the
Company in accordance with their terms, except as such enforceability may be limited by bankruptcy, insolvency, fraudulent transfer,
reorganization, moratorium and similar laws of general applicability, relating to or affecting creditors’ rights generally.


 


(c)          The
Securities are duly authorized and, when issued, delivered and paid for in the manner set forth in this Purchase Agreement, will
be validly issued, fully paid and non-assessable, and will conform in all material respects to the description thereof incorporated
by reference into the Offering Materials. In addition, such Securities will be free and clear of all liens, claims, charges, security
interests or agreements, pledges, assignments, covenants, restrictions or other encumbrances created by, or imposed by, the Company
and rights of refusal of any kind imposed by the Company (other than restrictions on transfer under applicable securities laws)
and the holder of such Securities shall be entitled to all rights accorded to a holder of the Company’s common stock.


 


(d)          The
execution, delivery and performance of the Transaction Documents by the Company and the consummation by the Company of the transactions
contemplated hereby do not and will not (i) violate any provision of the Company’s articles of incorporation or by-laws,
each as amended to date, (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would
become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement,
mortgage, deed of trust, indenture, note, bond, license, lease agreement, instrument or obligation to which the Company is a party
or by which the Company’s properties or assets are bound, or (iii) result in a violation of any federal, state, local or
foreign statute, rule, regulation, order, judgment or decree (including federal and state securities laws and regulations) applicable
to the Company or by which any property or asset of the Company is bound or affected, except, in the case of (ii) and (iii), for
such conflicts, defaults, terminations, amendments, acceleration, cancellations and violations as would not, individually or in
the aggregate, have a material adverse effect on the business, properties, management, financial position, stockholders’
equity, results of operation or prospects of the Company (a “Material Adverse Effect”). The Company is not required
under federal, state, foreign or local law, rule or regulation to obtain any consent, authorization or order of, or make any filing
or registration with, any court or governmental agency in order for it to execute, deliver or perform any of its obligations under
this Purchase Agreement or issue and sell the shares in accordance with the terms hereof (other than any filings, consents and
approvals which may be required to be made by the Company under applicable state and federal securities laws, rules or regulations
prior to or subsequent to the Closing).


 




    	5



    	 



    

 


(e)          The
Company has made available to the Investors through the U.S. Securities and Exchange Commission’s (the “SEC”)
EDGAR system, true and complete copies of the Company’s most recent Annual Report on Form 10-K for the fiscal year ended
December 31, 2012 (the “10-K”), and all other reports filed by the Company pursuant to the Securities Exchange Act
of 1934, as amended (the “Exchange Act”) since the filing of the 10-K and prior to the date hereof (collectively, the
“SEC Filings”). The SEC Filings are the only filings required of the Company pursuant to the Exchange Act for the period
from the filing of the 10-K through the date hereof.


 


(f)          At
the time of filing thereof, the SEC Filings complied as to form in all material respects with the requirements of the Exchange
Act and did not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein
or necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading.


 


(g)          As
of their respective dates, the financial statements of the Company included in the SEC Filings complied in all material respects
with applicable accounting requirements and the published rules and regulations of the SEC or other applicable rules and regulations
with respect thereto. Such financial statements have been prepared in accordance with United States generally accepted accounting
principles applied on a consistent basis during the periods involved (except (i) as may be otherwise indicated in such financial
statements or the notes thereto or (ii) in the case of unaudited interim statements, to the extent they may not include footnotes
or may be condensed or summary statements), and fairly present in all material respects the consolidated financial position of
the Company as of the dates thereof and the results of operations and cash flows for the periods then ended (subject, in the case
of unaudited statements, to normal year-end audit adjustments).


 


(h)          The
Company has established and maintains a system of internal accounting controls sufficient to provide reasonable assurances that:
(i) transactions are executed in accordance with management’s general or specific authorization; (ii) transactions are recorded
as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles in the United
States and to maintain accountability for assets; (iii) access to assets is permitted only in accordance with management’s
general or specific authorization; and (iv) the recorded accountability for assets is compared with existing assets at reasonable
intervals and appropriate action is taken with respect to any differences.


 




    	6



    	 



    

 


(i)          Except
as disclosed in the SEC Filings, since March 31, 2013, the Company has not (i) experienced or suffered any Material Adverse Effect,
(ii) incurred any material liabilities, obligations, claims or losses (whether liquidated or unliquidated, secured or unsecured,
absolute, accrued, contingent or otherwise) other than those incurred in the ordinary course of the Company’s business, or
(iii) declared, made or paid any dividend or distribution of any kind on its capital stock.


 


(j)          No
action, suit, proceeding or investigation is currently pending or, to the knowledge of the Company, has been threatened in writing
against the Company that: (i) concerns or questions the validity of this Purchase Agreement; (ii) concerns or questions the right
of the Company to enter into this Purchase Agreement; or (iii) is reasonably likely to have a Material Adverse Effect. The Company
is neither a party to nor subject to the provisions of any material order, writ, injunction, judgment or decree of any court or
government agency or instrumentality. There is no action, suit, proceeding or investigation by the Company currently pending or
that the Company intends to initiate that would have a Material Adverse Effect.


 


(k)          Neither
the Company nor any person acting on its behalf has conducted any general solicitation or general advertising (as those terms are
used in Regulation D) in connection with the offer or sale of any of the Securities.


 


(l)          The
Company is presently insured, and during each of the past two calendar years has been insured, for reasonable amounts with reputable
insurance companies against such risks as companies engaged in a similar business would, in accordance with good business practice,
customarily be insured.


 


(m)          Neither
the Company nor any of its subsidiaries nor, to the Company’s knowledge, any director, officer or employee of the Company
or any of its subsidiaries, acting on behalf of the Company or its subsidiaries, is aware of or has taken any action, directly
or indirectly, that would result in a violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended, and the
rules and regulations promulgated thereunder (the “FCPA”), including, without limitation, making use of the mails or
any means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization
of the payment of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any
“foreign official” (as such term is defined in the FCPA) or any foreign political party or official thereof or any
candidate for foreign political office, in contravention of the FCPA and the Company and its subsidiaries have conducted their
businesses in compliance with the FCPA and have instituted and maintain policies and procedures designed to ensure, and which are
reasonably expected to continue to ensure, continued compliance therewith.


 




    	7



    	 



    

 


(n)          Neither
the Company nor, to the Company’s knowledge, any director, officer or employee of the Company, acting on behalf of the Company,
is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department
(“OFAC”) and the Company will not directly or indirectly use the proceeds of the offering, or lend, contribute or otherwise
make available such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the
activities of any person currently subject to any U.S. sanctions administered by OFAC.


 


(o)          The
Company and each of its subsidiaries has (i) timely filed all United States federal, state and local tax returns, information returns,
and similar reports that are required to be filed (taking into account valid extensions), and all tax returns are true, correct
and complete in all material respects, (ii) paid in full all taxes shown as due thereon and any other assessment, fine or penalty
levied against it, except for any such assessment, fine or penalty that is currently being contested in good faith or as would
not, individually or in the aggregate, have a Material Adverse Effect, and (iii) established on the most recent balance sheet reserves
that are adequate for the payment of all taxes not yet due and payable.


 


(p)          The
Company is in compliance in all material respects with all of the provisions of the Sarbanes-Oxley Act of 2002 which are applicable
to it. The Company has established disclosure controls and procedures (as such term is defined in Rule 13a-15(e) and 15d-15(e)
under the Exchange Act) for the Company and designed such disclosure controls and procedures to ensure that information required
to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and
reported, within the time periods specified in the Commission’s rules and forms. The Company’s certifying officers
have evaluated the effectiveness of the Company’s disclosure controls and procedures as of the end of the period covered
by the Company’s most recently filed periodic report under the Exchange Act (such date, the “Evaluation Date”).
The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers
about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the
Evaluation Date, there have been no changes in the Company’s internal control over financial reporting (as such term is defined
in the Exchange Act) that have materially affected, or are reasonably likely to materially affect, the Company’s internal
control over financial reporting.


 


(q)          The
Company is not, and immediately after receipt of payment for the Securities will not be, an “investment company,” an
“affiliated person” of, “promoter” or “principal underwriter” for, an entity “controlled”
by an “investment company,” within the meaning of the Investment Company Act of 1940, as amended.


 




    	8



    	 



    

 


8.          Representations
and Warranties of the Undersigned. The undersigned hereby represents and warrants to and covenants with the Company that:


 


(a)          General.


 


(i)          Each
undersigned Investor is duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation
or organization with the requisite power and authority to purchase the Securities to be purchased by it hereunder and to execute
and deliver the Transaction Documents, and such purchase will not contravene any law, rule or regulation binding on the undersigned
or any investment guideline or restriction applicable to the undersigned.


 


(ii)         Assuming
the due authorization, execution and delivery thereof by the Company, the Transaction Documents constitute such Investor’s
valid and legally binding obligation, enforceable against such Investor in accordance with their respective terms, subject to bankruptcy,
insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability, relating to or affecting
creditors’ rights generally.


 


(iii)        The
undersigned Investor is a resident of the state set forth on the signature page hereto and is not acquiring the Securities as a
nominee or agent or otherwise for any other person.


 


(iv)        The
undersigned Investor is not a broker-dealer registered with the SEC under the Exchange Act, or a member of the Financial Industry
Regulatory Authority Inc., or an entity engaged in a business that would require it to be so registered.


 


(v)         The
undersigned will comply with all applicable laws and regulations in effect in any jurisdiction in which the undersigned purchases
or sells Securities and obtain any consent, approval or permission required for such purchases or sales under the laws and regulations
of any jurisdiction to which the undersigned is subject or in which the undersigned makes such purchases or sales, and the Company
shall have no responsibility therefor.


 


(vi)        The
execution, delivery and performance by such Investor of the Transaction Documents and the consummation by such Investor of the
transactions contemplated hereby and thereby will not (i) result in a violation of the organizational documents of such Investor,
(ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under,
or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument
to which such Investor is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including
federal and state securities laws) applicable to such Investor, except in the case of clauses (ii) and (iii) above, for such conflicts,
defaults, rights or violations which would not, individually or in the aggregate, reasonably be expected to have a material adverse
effect on the ability of such Investor to perform its obligations hereunder.


 




    	9



    	 



    

 


(b)          Information
Concerning the Company.


 


(i)          The
undersigned has received a copy of the Offering Materials. The undersigned has not been furnished any offering information from
the Company or any placement agent relating to the offering of the Securities other than the Offering Materials and has relied
only on the information contained therein.


 


(ii)         The
undersigned confirms that it is not relying on any communication (written or oral) of the Company or any of its affiliates, as
investment advice or as a recommendation to purchase the Securities. It is understood that information and explanations related
to the terms and conditions of the Securities provided in the Offering Materials or otherwise by the Company or any of its affiliates
shall not be considered investment advice or a recommendation to purchase the Securities, and that neither the Company nor any
of its affiliates is acting or has acted as an advisor to the undersigned in deciding to invest in the Securities. The undersigned
acknowledges that neither the Company nor any of its affiliates has made any representation regarding the proper characterization
of the Securities for purposes of determining the undersigned’s authority to invest in the Securities.


 


(iii)        The
undersigned is familiar with the business and financial condition and operations of the Company, all as generally described in
the Offering Materials. The undersigned has had access to such information concerning the Company and the Securities as it deems
necessary to enable it to make an informed investment decision concerning the purchase of the Securities.


 


(iv)        The
undersigned understands that, unless the undersigned notifies the Company in writing to the contrary at or before the Closing Date,
each of the undersigned’s representations and warranties contained in this Purchase Agreement will be deemed to have been
reaffirmed and confirmed as of the Closing Date, taking into account all information received by the undersigned.


 


(v)         The
undersigned understands that no federal or state agency has passed upon the merits or risks of an investment in the Securities
or made any finding or determination concerning the fairness or advisability of this investment.


 


(vi)        The
undersigned Investor represents and warrants that it has not, as of the date of this Purchase Agreement and will not (i) use any
information contained in the Offering Materials or any purpose other than an evaluation of potential investment in the Securities
or (ii) disclose any such information publicly or to any third party (other than those persons, if any, retained to advise such
Investor with respect to its potential investment).


 




    	10



    	 



    

 


(vii)       The
undersigned Investor understands and acknowledges that (A) the Company previously filed a registration statement on Form S-1 with
the SEC (File 333-188497) on May 9, 2013 (such registration statement, including the exhibits and any amendments thereto, the “Registration
Statement”) and subsequently withdrew such Registration Statement pursuant to Rule 477 of the Securities Act, effective as
of May 15, 2013, (B) no securities were sold under such Registration Statement, (C) the offer and sale of the Securities being
sold hereunder will not be registered under the Securities Act, (D) the Securities being sold hereunder will be “restricted
securities” as such term is defined under Rule 144(a)(3) under the Securities Act and may not be resold except in accordance
with the legend affixed to the face of the certificates evidencing the Securities and the provisions of Section 8(e) hereof, and
(E) such Investor does not have the protection of Section 11 of the Securities Act in connection with its purchase of the Securities
hereunder. As of July 9, 2013, six months have elapsed since the closing date of the private placement transaction in connection
with which the Registration Statement was filed. Each named selling stockholder included in the Registration Statement may, subject
to the limitations set forth in Rule 144 promulgated under the Securities Act (“Rule 144”) and the individual determination
of the status of each selling stockholder, avail themselves of the applicable provisions of Rule 144 for sales of the Company’s
common stock.


 


(c)          Non-reliance.


 


(i)          The
undersigned represents that it is not relying on (and will not at any time rely on) any communication (written or oral) of the
Company or Merrill Lynch, Pierce, Fenner & Smith Incorporated (“Merrill Lynch”), as investment advice or as a recommendation
to purchase the Securities, it being understood that information and explanations related to the terms and conditions of the Securities
and the other Transaction Documents that are described in the Offering Materials shall not be considered investment advice or a
recommendation to purchase the Securities.


 


(ii)         The
undersigned confirms that neither the Company nor Merrill Lynch have (A) given any guarantee or representation as to the potential
success, return, effect or benefit (either legal, regulatory, tax, financial, accounting or otherwise) of an investment in the
Securities or (B) made any representation to the undersigned regarding the legality of an investment in the Securities under applicable
legal investment or similar laws or regulations. In deciding to purchase the Securities, the undersigned is not relying on the
advice or recommendations of the Company or Merrill Lynch and the undersigned has made its own independent decision that the investment
in the Securities is suitable and appropriate for the undersigned.


 




    	11



    	 



    

 


(d)          Status
of Undersigned.


 


(i)          The
undersigned understands and accepts that the purchase of the Securities involves various risks, including the risks outlined in
the Offering Materials and in this Purchase Agreement. The undersigned has such knowledge, skill and experience in business, financial
and investment matters that the undersigned is capable of evaluating the merits and risks of an investment in the Securities. With
the assistance of the undersigned’s own professional advisors, to the extent that the undersigned has deemed appropriate,
the undersigned has made its own legal, tax, accounting and financial evaluation of the merits and risks of an investment in the
Securities and the consequences of this Purchase Agreement. The undersigned has considered the suitability of the Securities as
an investment in light of its own circumstances and financial condition and the undersigned is able to bear the risks associated
with an investment in the Securities and its authority to invest in the Securities.


 


(ii)         The
undersigned is an “accredited investor” as defined in Rule 501(a) under the Securities Act. The undersigned agrees
to furnish any additional information requested by the Company or any of its affiliates to assure compliance with applicable U.S.
federal and state securities laws in connection with the purchase and sale of the Securities. The undersigned acknowledges that
the undersigned has completed, duly executed and delivered to the Company’s placement agent, an investor questionnaire in
a form reasonably satisfactory to the placement agent and that the information contained therein is complete and accurate as of
the date thereof and is hereby affirmed as of the date hereof.


 


(e)          Restrictions
on Transfer or Sale of Securities. As applies to the undersigned:


 


(i)          The
undersigned is acquiring the Securities solely for the undersigned’s own beneficial account, for investment purposes, and
not with a view to, or for resale in connection with, any distribution of the Securities. The undersigned understands that the
Securities have not been registered under the Securities Act or any state securities laws by reason of specific exemptions under
the provisions thereof which depend in part upon the investment intent of the undersigned and of the other representations made
by the undersigned in this Purchase Agreement. The undersigned understands that the Company is relying upon the representations
and agreements contained in this Purchase Agreement (and any supplemental information) for the purpose of determining whether this
transaction meets the requirements for such exemptions.


 


(ii)         The
undersigned understands that the Securities are “restricted securities” under applicable federal securities laws and
that the Securities Act and the rules of the SEC provide in substance that the undersigned may dispose of the Securities only pursuant
to an effective registration statement under the Securities Act or an exemption therefrom, and the undersigned understands that,
except as set forth in the Registration Rights Agreement, the Company has no obligation or intention to register any of the Securities,
or to take action so as to permit sales pursuant to the Securities Act (including Rule 144 thereunder). Accordingly, the undersigned
understands that under the SEC’s rules and other than as set forth in the Registration Rights Agreement, the undersigned
may dispose of the Securities principally only in “private placements” which are exempt from registration under the
Securities Act, in which event the transferee will acquire “restricted securities” subject to the same limitations
as in the hands of the undersigned. Consequently, the undersigned understands that the undersigned must bear the economic risks
of the investment in the Securities for an indefinite period of time.


 




    	12



    	 



    

 


(iii)        The
undersigned agrees: (A) that the undersigned will not sell, assign, pledge, give, transfer or otherwise dispose of the Securities
or any interest therein, or make any offer or attempt to do any of the foregoing, except pursuant to a registration of the Securities
under the Securities Act and all applicable state securities laws, or in a transaction which is exempt from the registration provisions
of the Securities Act and all applicable state securities laws; (B) that the certificates evidencing the Securities will bear a
legend substantially in the form set out below, making reference to the foregoing restrictions; and (C) that the Company, its transfer
agent and their affiliates shall not be required to give effect to any purported transfer of such Securities except upon compliance
with the foregoing restrictions. The legend on the certificates representing the Securities shall state:


 


THE SECURITIES REPRESENTED
HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),
OR ANY STATE SECURITIES LAWS. THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES FOR THE BENEFIT OF THE ISSUER THAT THESE
SECURITIES MAY BE OFFERED, SOLD OR OTHERWISE TRANSFERRED ONLY (A) TO THE ISSUER, (B) PURSUANT TO REGISTRATION UNDER THE SECURITIES
ACT, (C) OUTSIDE THE UNITED STATES PURSUANT TO REGULATION S UNDER THE SECURITIES ACT, (D) INSIDE THE UNITED STATES PURSUANT TO
THE EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER, IF AVAILABLE, OR (E) IN A TRANSACTION
THAT IS OTHERWISE EXEMPT FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT, AND IN EACH CASE IN COMPLIANCE WITH APPLICABLE
STATE SECURITIES LAWS AND THE APPLICABLE LAWS OF ANY OTHER JURISDICTION, PROVIDED THAT IN THE CASE OF (C), (D) or (E) ABOVE, THE
HOLDER HAS, PRIOR TO SUCH SALE, FURNISHED TO THE ISSUER A LEGAL OPINION OF COUNSEL OF RECOGNIZED STANDING, REASONABLY SATISFACTORY
TO THE ISSUER. HEDGING TRANSACTIONS INVOLVING THESE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.


 


(iv)        The
undersigned acknowledges that neither the Company nor any other person offered to sell the Securities to it by means of any form
of general solicitation or advertising, including but not limited to: (A) any advertisement, article, notice or other communication
published in any newspaper, magazine or similar media or broadcast over television or radio or (B) any seminar or meeting whose
attendees were invited by any general solicitation or general advertising.


 




    	13



    	 



    

 


9.          Reliance
Upon Representations and Warranties. Each Investor understands and acknowledges that the Securities are being offered and sold
in reliance on a transactional exemption from the registration requirements of federal and state securities laws, and that the
Company and Merrill Lynch are relying upon the truth and accuracy of the representations, warranties, agreements, acknowledgments
and understandings of such Investor set forth in this Agreement (i) in concluding that the offer and sale of the Securities is
a “private offering” and, as such, is exempt from the registration requirements of the Securities Act, and (ii) to
determine the applicability of such exemptions in evaluating the suitability of such Investor to purchase the Securities.


 


10.         Furnishing
of Information. For a period of one year after the date of this Purchase Agreement, the Company covenants to file all reports
required to be filed by the Company after the date hereof pursuant to the Exchange Act. During this one-year period, if the Company
is not required to file reports pursuant to the Exchange Act, it will prepare and furnish to the Investors and make publicly available
in accordance with Rule 144 such information as is required for the Investors to sell the Securities under Rule 144.


 


11.         No
Integration. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security
(as defined in Section 2 of the Securities Act) that could reasonably be expected to be integrated with the offer or sale of the
Securities in a manner that would require the registration under the Securities Act of the sale of the Securities to the Investors.


 


12.         Publicity;
Certain Transactions. The Company shall not publicly disclose the name of any Investor or an affiliate of any Investor, or
include the name of any Investor or an affiliate of any Investor in any press release or filing with the SEC (other than any registration
statement to be filed in connection with the Registration Rights Agreement) or any regulatory agency or trading market, without
the prior written consent of such Investor, except (i) as required by federal securities law in connection with (A) any registration
statement contemplated by the Registration Rights Agreement and (B) the filing of the final Transaction Documents (including signature
pages thereto) with the SEC and (ii) to the extent such disclosure is required by law, requested by the staff of the SEC or trading
market regulations, in which case the Company shall provide the Investors with notice as soon as reasonably practicable of such
disclosure permitted under this subclause (ii). Except as prohibited by law or any rule or regulation of any securities exchange
or any governmental agency, the Company shall use its commercially reasonable efforts to provide such notice in advance of any
anticipated public disclosure as contemplated by clauses (i) and (ii) above and permit the Investors to review and provide comments
to such public disclosure. Each Investor acknowledges that the Offering Materials contain non-public information regarding acquisitions
being contemplated by the Company that are currently material to the Company’s prospects and that trading in the Company’s
securities while in possession of this information would be a violation of applicable securities laws until the date on which such
information is either (i) publicly disclosed or (ii) is no longer material (the “Cleansing Date”). In order to give
more certainty to Investors, the Company agrees to promptly notify (“Cleansing Notice”) each Investor when, in the
Company’s good faith determination, the Cleansing Date has occurred. The Company shall use its commercially reasonable efforts
to effect the Cleansing Date as soon as reasonably practical following the Closing Date and in no event later than September 30,
2013. Each Investor acknowledges that a Cleansing Notice represents only the Company’s good faith determination that the
Cleansing Date has occurred and a legal or regulatory authority or trading counterparty may come to a different conclusion as to
whether and when the Cleansing Date has occurred.


 




    	14



    	 



    

 


13.         Indemnification
of Investors. In addition to the indemnity set forth in the Registration Rights Agreement, the Company agrees to indemnify
and hold harmless each Investor and its affiliates and their respective directors, officers, trustees, members, managers, employees
and agents, and their respective successors and assigns, from and against any and all losses, claims, damages, liabilities and
expenses (including without limitation reasonable attorney fees and disbursements and other expenses incurred in connection with
investigating, preparing or defending any action, claim or proceeding, pending or threatened and the costs of enforcement thereof)
to which such person may become subject as a result of any breach of representation, warranty, covenant or agreement made by or
to be performed on the part of the Company under the Transaction Documents, and will reimburse any such person for all such amounts
as they are incurred by such person.


 


14.         Rule
13d-5. Each of the Investors hereby agree and acknowledge that, no Investor or its affiliates has an agreement to act, or is
acting, together or in concert with, any other Investor or its affiliates, for or in furtherance of the purpose of (i) acquiring,
holding, voting or disposing of securities of the Company, (ii) seeking to control the management, the board of directors or policies
of the Company or (iii) effecting or seeking to effect any action, transaction, change or matter referred to in any one or more
of clauses (a) through (j) of Item 4 of Schedule 13D under the Exchange Act, or otherwise are or shall be deemed to be acting in
concert with each other, for or in furtherance of any such purpose (such action or agreement to act for such enumerated purpose
or purposes, a “Group Action”). The Company is not aware of any Investor or Investors or their respective affiliates
having any agreement to take or currently taking any Group Action.


 


15.         Obligations
Irrevocable. The obligations of the undersigned shall be irrevocable.


 




    	15



    	 



    

 


16.         Waiver;
Amendment. Neither this Purchase Agreement nor any provisions hereof shall be modified, changed, discharged or terminated except
by an instrument in writing, signed by the party against whom any waiver, change, discharge or termination is sought.


 


17.         Assignability.
Neither this Purchase Agreement nor any right, remedy, obligation or liability arising hereunder or by reason hereof shall be assignable
by either the Company or the undersigned without the prior written consent of the other party.


 


18.         Waiver
of Jury Trial. Each of the parties to this Purchase Agreement hereby agrees to waive its respective rights to a jury trial
of any claim or cause of action based upon or arising out of this Purchase Agreement. The scope of this waiver is intended to be
all-encompassing of any and all disputes that may be filed in any court and that relate to the subject matter of this Purchase
Agreement, including contract claims, tort claims and all other common law and statutory claims. Each party hereto acknowledges
that this waiver is a material inducement to enter into this Purchase Agreement, that each has already relied on this waiver in
entering into this Purchase Agreement, and that each will continue to rely on this waiver in their related future dealings. Each
party hereto further warrants and represents that it has reviewed this waiver with its legal counsel and that it knowingly and
voluntarily waives its jury trial rights following consultation with legal counsel. THIS WAIVER IS IRREVOCABLE, MEANING THAT IT
MAY NOT BE MODIFIED EITHER ORALLY OR IN WRITING (OTHER THAN BY A MUTUAL WRITTEN WAIVER SPECIFICALLY REFERRING TO THIS SECTION 18
AND EXECUTED BY EACH OF THE PARTIES HERETO), AND THIS WAIVER SHALL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS OR
MODIFICATIONS TO THIS PURCHASE AGREEMENT. In the event of litigation, this Purchase Agreement may be filed as a written consent
to a trial by the court.


 


19.         Submission
to Jurisdiction. With respect to any suit, action or proceeding relating to any offers, purchases or sales of the Securities
by the undersigned (“Proceedings”), the undersigned irrevocably
submits to the jurisdiction of the federal or state courts located in the Borough of Manhattan in New York City, which submission
shall be exclusive unless none of such courts has lawful jurisdiction over such Proceedings.


 


20.         Governing
Law. This Purchase Agreement shall be governed by and construed in accordance with the laws of the State of New York.


 


21.         Section
and Other Headings. The section and other headings contained in this Purchase Agreement are for reference purposes only and
shall not affect the meaning or interpretation of this Purchase Agreement.


 


22.         Counterparts.
This Purchase Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be deemed
to be an original and all of which together shall be deemed to be one and the same agreement.


 




    	16



    	 



    

 


23.         Notices.
All notices and other communications provided for herein shall be in writing and shall be deemed to have been duly given if delivered
personally or sent by registered or certified mail, return receipt requested, postage prepaid to the following addresses (or such
other address as either party shall have specified by notice in writing to the other):


 


	If to the Company:	Sequential Brands Group, Inc.
	 	1065 Avenue of the Americas
	 	30th Floor
	 	New York, NY 10018
	 	Facsimile:	(212) 354-8113
	 	Attention:	Yehuda Shmidman
	with a copy (which shall not 	White & Case LLP
	constitute notice) to:	1155 Avenue of the Americas
	 	New York, New York 10036
	 	Facsimile:  	(212) 354-8113
	 	Attention:	Nazim Zilkha
	 	 	David Johansen


 


Notices to the Investors
shall be sent to the addresses indicated on their respective signature pages hereto.


 


24.         Delivery
by Facsimile. This Purchase Agreement, the agreements referred to herein, and each other agreement or instrument entered into
in connection herewith or therewith or contemplated hereby or thereby, and any amendments hereto or thereto, to the extent signed
and delivered by means of a facsimile machine or other electronic means, shall be treated in all manner and respects as an original
agreement or instrument and shall be considered to have the same binding legal effect as if it were the original signed version
thereof delivered in person. At the request of any party hereto or to any such agreement or instrument, each other party hereto
or, thereto shall reexecute original forms thereof and deliver them to all other parties. No party hereto or to any such agreement
or instrument shall raise the use of a facsimile machine or other electronic means to deliver a signature or the fact that any
signature or agreement or instrument was transmitted or communicated through the use of a facsimile machine or other electronic
means as a defense to the formation or enforceability of a contract and each such party forever waives any such defense.


 


25.         Binding
Effect. The provisions of this Purchase Agreement shall be binding upon and accrue to the benefit of the parties hereto and
their respective heirs, legal representatives, successors and assigns.


 




    	17



    	 



    

 


26.         Arm’s
Length Agreement. Each of the parties to this Purchase Agreement agrees and acknowledges that this Purchase Agreement has been
negotiated in good faith, at arm’s length, and not by any means prohibited by law.


 


27.         Sophisticated
Parties; Advice of Counsel. Each of the parties to this Purchase Agreement specifically acknowledges that (i) it is a knowledgeable,
informed, sophisticated person capable of understanding and evaluating the provisions set forth in this Purchase Agreement and
(ii) it has been fully advised and represented by internal or outside legal counsel of its own independent selection and has relied
wholly upon its independent judgment and the advice of such counsel in negotiating and entering into this Purchase Agreement.


 


28.         Entire
Agreement. This Purchase Agreement, together with the appendices, schedules and exhibits attached hereto, and any certificates,
documents, instruments and writings that are delivered pursuant hereto, constitutes the entire agreement and understanding of the
parties in respect of the subject matter hereof and supersedes all prior understandings, agreements or representations by or among
the parties, written or oral, to the extent they relate in any way to the subject matter hereof.


 


29.         Survival.
All representations, warranties and covenants contained in this Purchase Agreement shall survive (i) the acceptance of the subscription
by the Company, (ii) changes in the transactions, documents and instruments described in the Offering Materials which are not material
or which are to the benefit of the undersigned and (iii) the death or disability of the undersigned.


 


30.         Notification
of Changes. The undersigned hereby covenants and agrees to notify the Company upon the occurrence of any event prior to the
Closing pursuant to this Purchase Agreement which would cause any representation, warranty, or covenant of the undersigned contained
in this Purchase Agreement to be false or incorrect.


 


31.         Severability.
If any term or provision of this Purchase Agreement is invalid, illegal or unenforceable in any jurisdiction, such invalidity,
illegality or unenforceability shall not affect any other term or provision of this Purchase Agreement or invalidate or render
unenforceable such term or provision in any other jurisdiction.


 


[SIGNATURE PAGE FOLLOWS]


 




    	18



    	 



    

 


IN WITNESS WHEREOF, the undersigned has
executed this Purchase Agreement as of the date first written above.


 


	Investor Name:	 	 


 


	By	 	 
	Name:	 	 
	Title:	 	 


 


	Registered Address:	 
	 	 
	 	 
	 	 


 


	Tax ID #:	 	 


 


Investor Purchase Amount:


	US$	 	 





 


Signature Page to the Purchase Agreement


 




    	 



    	 



    

 


Acknowledged and agreed by:


 


	 	Sequential Brands Group, Inc.
	 	 	 
	 	By	 
	 	Name:	 
	 	Title:	 


  


Signature Page to the Purchase Agreement


 




    	 



    	 



    

 


SCHEDULE 1


 


Offering
Materials


 


1.          Slide
Deck entitled “Sequential Brands Group – Investment Overview”


 




    	 



    	 



    

 


APPENDIX
A


Consideration
To Be Delivered


 


	Investor Name and

Registered Address	 	Securities to Be

Acquired	 	Purchase Price to be

Paid*
	 	 	______ shares of 

common stock	 	US$_____
	 	 	
        Total Shares: 

        ______
	 	
        Total Purchase Price:

        $________



 


*Rounded for reference purposes.